未登录

M

Manoj K. Pandey

Cooper Medical School of Rowan University

H指数:40

被引数:8,149

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Wired to Survive: How AML Cytogenetics Shape Apoptotic Dependence and Venetoclax Resistance

wired to Survive: AML细胞遗传学如何塑造凋亡依赖性和维奈克拉耐药性

IF2.8

2026-09-160

OA

Quality of life trajectory in breast cancer survivors: A longitudinal, two-year post treatment follow-up study

Journal of Psychosomatic Research

IF3.3

2026-01-200

PRE

Misdiagnosis to Cure: Surgery and Thalidomide's Role in Cervical Metastatic Malignant Melanoma with Long-Term Survival

误诊到治愈：手术和沙利度胺在长期生存的宫颈转移性恶性黑色素瘤中的作用

Indian Journal of Surgery

IF0.4

2026-01-010

PRE

Saga of MCL1 inhibitors in multiple myeloma

MCL1抑制剂在多发性骨髓瘤中的研究历程

Biochemical Pharmacology

IF5.6

2025-11-070

PRE

Unlocking nature's potential: Soursop in the battle against resistant acute myeloid leukemia

Biochemistry and Biophysics Reports

IF2.2

2025-11-010

OAAI

The Largest Reported 'Asymptomatic' Calculous in the Submandibular Gland 'Parenchyma'

INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY

IF0.4

2025-10-010

PRE

Tumor tough, therapy smarter: Rethinking CAR-T for pancreatic cancer

肿瘤顽固，疗法更智能：重新思考CAR-T治疗胰腺癌

Seminars in Oncology

IF2.5

2025-09-040

OAAI

Editorial: Immunotherapy: up to date progress in childhood and hematological malignancies

FRONTIERS IN ONCOLOGY

IF3.3

2025-03-270

OAAI

An unusual case of post-menopausal bleeding

绝经后出血的罕见病例

world journal of clinical oncology

IF2.5

2025-02-040

OA

Unveiling the intricate dance: Obesity and TNBC connection examined

IF5.1

2024-11-010

OAAI

Is it possible to treat melanoma by intercepting the CXCR4/ CXCL12 pathway?

是否有可能通过阻断CXCR4/ CXCL12通路来治疗黑色素瘤？

IF3.7

2024-07-011

OAAI

Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells

IF3.6

2024-06-012

OAAI

The development of a small molecule dual inhibitor of CXCR4 and Mcl-1 to target bortezomib resistant and stem-like cells in multiple myeloma

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Venetoclax triggers apoptosis and augments the effectiveness of doxorubicin against acute myeloid leukemia cells

CANCER RESEARCH

IF16.6

2024-03-220

PRE

KS18, an Mcl-1 inhibitor, triggers cell death and enhances the therapeutic efficacy of venetoclax in bortezomib-resistant multiple myeloma cells

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Mcl-1 inhibitor KS18 overcomes bortezomib, venetoclax, and ABT-737 resistance in multiple myeloma

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Past, Present, and a Glance into the Future of Multiple Myeloma Treatment

PHARMACEUTICALS

IF4.8

2023-03-0813

OAAI

The emerging role of non-coding RNAs in the epigenetic regulation of pediatric cancers

非编码rna在儿童癌症表观遗传调控中的新兴作用

SEMINARS IN CANCER BIOLOGY

IF15.7

2022-08-0115

PREAI

A Novel Dialkylamino-Functionalized Chalcone, DML6, Inhibits Cervical Cancer Cell Proliferation, In Vitro, via Induction of Oxidative Stress, Intrinsic Apoptosis and Mitotic Catastrophe

IF4.6

2021-07-119

OAAI

COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges

IF13.3

2021-01-0169

OAAI